DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Stemmler HJ, Harbeck N, Gröll de Rivera I. et al.
Prospective multicenter randomized phase III study of weekly versus standard docetaxel (D2) for first-line treatment of metastatic breast cancer.
Oncology 2010;
79: 197-203
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.